PBYI vs AAPL: Which Stock is Better?

Side-by-side comparison of Puma Biotechnology Inc and Apple Inc in 2026

Comparison Updated:

PBYI

Puma Biotechnology Inc

$7.47

AAPL

Apple Inc

$269.84

Key Metrics Comparison

MetricPBYIAAPLWinner
Market Cap$368.35MN/APBYI
P/E Ratio11.8733.32PBYI
EPS (TTM)$0.61$8.11AAPL
Revenue Growth0.3%0.2%PBYI
Gross Margin74.5%47.3%PBYI

Analyze PBYI

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PBYI or AAPL a better investment?

Comparing PBYI and AAPL: Puma Biotechnology Inc has a market cap of $368.35M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PBYI and AAPL?

PBYI (Puma Biotechnology Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PBYI or AAPL?

Based on P/E ratios, PBYI trades at a lower multiple (11.9x vs 33.3x).

Which is growing faster: PBYI or AAPL?

PBYI has higher revenue growth at 0.3% vs 0.2% for AAPL.

Which company is more profitable: PBYI or AAPL?

Puma Biotechnology Inc (PBYI) has higher gross margins at 74.5% compared to 47.3% for AAPL.

Which is the larger company: PBYI or AAPL?

Puma Biotechnology Inc (PBYI) is larger with a market cap of $368.35M compared to N/A for AAPL.

Should I buy PBYI or AAPL in 2026?

Both PBYI and AAPL have investment merit. PBYI trades at $7.47 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PBYI and AAPL stock?

Key differences: Market Cap ($368.35M vs N/A), P/E Ratio (11.9x vs 33.3x), Revenue Growth (0.3% vs 0.2%), Gross Margin (74.5% vs 47.3%).

Popular Stock Comparisons